Reference,Reference: DOI,Assay,Section,Infection (CP),Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Tada22b,10.1016/j.celrep.2021.110237,Pseudovirus (lentivirus),Supplementary Table 1,Unknown variant,2-6m,Human,Wild Type (B.1),=,239.0,1.0,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,96.0,1.0,=,2.5
Tada22b,10.1016/j.celrep.2021.110237,Pseudovirus (lentivirus),Supplementary Table 1,Unknown variant,2-6m,Human,Wild Type (B.1),=,167.0,1.0,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,92.0,1.0,=,1.8
Tada22b,10.1016/j.celrep.2021.110237,Pseudovirus (lentivirus),Supplementary Table 1,Unknown variant,2-6m,Human,Wild Type (B.1),=,74.0,1.0,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,171.0,1.0,=,0.4
Tada22b,10.1016/j.celrep.2021.110237,Pseudovirus (lentivirus),Supplementary Table 1,Unknown variant,2-6m,Human,Wild Type (B.1),=,394.0,1.0,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,56.0,1.0,=,7.0
Tada22b,10.1016/j.celrep.2021.110237,Pseudovirus (lentivirus),Supplementary Table 1,Unknown variant,2-6m,Human,Wild Type (B.1),=,583.0,1.0,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,59.0,1.0,=,9.9
Tada22b,10.1016/j.celrep.2021.110237,Pseudovirus (lentivirus),Supplementary Table 1,Unknown variant,2-6m,Human,Wild Type (B.1),=,369.0,1.0,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,105.0,1.0,=,3.5
Tada22b,10.1016/j.celrep.2021.110237,Pseudovirus (lentivirus),Supplementary Table 1,Unknown variant,2-6m,Human,Wild Type (B.1),=,503.0,1.0,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,66.0,1.0,=,7.6
Tada22b,10.1016/j.celrep.2021.110237,Pseudovirus (lentivirus),Supplementary Table 1,Unknown variant,2-6m,Human,Wild Type (B.1),=,345.0,1.0,Delta,19,T19R + G142D + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,77.0,1.0,=,4.5
Tada22b,10.1016/j.celrep.2021.110237,Pseudovirus (lentivirus),Supplementary Table 1,Unknown variant,2-6m,Human,Wild Type (B.1),=,239.0,1.0,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,52.0,1.0,=,4.6
Tada22b,10.1016/j.celrep.2021.110237,Pseudovirus (lentivirus),Supplementary Table 1,Unknown variant,2-6m,Human,Wild Type (B.1),=,167.0,1.0,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,77.0,1.0,=,2.2
Tada22b,10.1016/j.celrep.2021.110237,Pseudovirus (lentivirus),Supplementary Table 1,Unknown variant,2-6m,Human,Wild Type (B.1),=,74.0,1.0,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,167.0,1.0,=,0.4
Tada22b,10.1016/j.celrep.2021.110237,Pseudovirus (lentivirus),Supplementary Table 1,Unknown variant,2-6m,Human,Wild Type (B.1),=,394.0,1.0,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,<,48.0,1.0,>,8.2
Tada22b,10.1016/j.celrep.2021.110237,Pseudovirus (lentivirus),Supplementary Table 1,Unknown variant,2-6m,Human,Wild Type (B.1),=,583.0,1.0,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,98.0,1.0,=,5.9
Tada22b,10.1016/j.celrep.2021.110237,Pseudovirus (lentivirus),Supplementary Table 1,Unknown variant,2-6m,Human,Wild Type (B.1),=,369.0,1.0,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,62.0,1.0,=,6.0
Tada22b,10.1016/j.celrep.2021.110237,Pseudovirus (lentivirus),Supplementary Table 1,Unknown variant,2-6m,Human,Wild Type (B.1),=,503.0,1.0,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,106.0,1.0,=,4.7
Tada22b,10.1016/j.celrep.2021.110237,Pseudovirus (lentivirus),Supplementary Table 1,Unknown variant,2-6m,Human,Wild Type (B.1),=,345.0,1.0,Delta,19,T19R + E156G + Δ157-158 + L452R + T478K + P681R + D950N,1,=,83.0,1.0,=,4.2